Celator Pharma Cmn (CPXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,402 | -13,725 | -9,684 | -10,909 | -10,367 |
| Depreciation Amortization | 148 | 97 | 48 | 412 | 253 |
| Accounts receivable | 1,991 | 1,994 | 1,884 | -783 | 1,114 |
| Accounts payable and accrued liabilities | -22 | -49 | -102 | 198 | 322 |
| Other Working Capital | 860 | 863 | 1,621 | 1,249 | 3,162 |
| Other Operating Activity | 6,028 | 5,829 | 4,969 | 4,864 | 2,811 |
| Operating Cash Flow | $-8,398 | $-4,991 | $-1,264 | $-4,968 | $-2,706 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | 1 | 30 | 26 | 14 |
| Investing Cash Flow | $-30 | $1 | $30 | $26 | $14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,423 | 5,423 |
| Debt Repayment | -3,000 | -3,000 | -300 | N/A | N/A |
| Common Stock Issued | 32,500 | 32,500 | N/A | 6,763 | 6,222 |
| Other Financing Activity | -3,080 | -3,080 | 0 | -837 | -782 |
| Financing Cash Flow | $26,420 | $26,420 | $-300 | $11,349 | $10,863 |
| Exchange Rate Effect | 1 | 2 | -4 | 14 | N/A |
| Beginning Cash Position | 9,648 | 9,648 | 9,648 | 3,227 | 3,227 |
| End Cash Position | 27,642 | 31,080 | 8,110 | 9,648 | 11,397 |
| Net Cash Flow | $17,994 | $21,432 | $-1,538 | $6,421 | $8,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,398 | -4,991 | -1,264 | -4,968 | -2,706 |
| Capital Expenditure | -82 | -36 | N/A | -36 | -18 |
| Free Cash Flow | -8,480 | -5,027 | -1,264 | -5,004 | -2,724 |